Transplantation

Aims & Scope

The journal celebrated its 50th year in 2016.

Transplantation has been the trusted source for extensive and timely coverage of the most important advances in transplantation.

The Editors and Editorial Board are an international group of research and clinical leaders that includes many pioneers of the field, representing a diverse range of areas of expertise.

This capable editorial team provides thoughtful and thorough peer review, and delivers rapid, careful and insightful editorial evaluation of all manuscripts submitted to the journal.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	5
2024	5.30

SJR (SCImago Journal Rank)

Year	Value
2024	1.325

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	224

Journal Rank

Year	Value
2024	2992

Journal Citation Indicator

Year	Value
2024	4020

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S

  Citation: 3025

  Authors: H., R., A., C. D., P. E., R. A., K. G., E. D.

• HETEROTOPIC TRANSPLANTS OF BONE MARROW

  Citation: 1595

  Authors: ALEXANDER JAKOVLEVICH, KLARA VASILJEVNA, ALEXANDRA IVANOVNA, GALINA PETROVNA

• Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

  Citation: 1206

  Authors: William T., John D., Wendy M., Matthew C., Eva C.

• MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTS

  Citation: 1121

  Authors: H. W.

• STROMAL CELLS RESPONSIBLE FOR TRANSFERRING THE MICROENVIRONMENT OF THE HEMOPOIETIC TISSUES

  Citation: 1108

  Authors: Alexander J., Ruben K., Nataly V., Andrey F., Iren V.

• PRINCIPLES OF SOLID-ORGAN PRESERVATION BY COLD STORAGE

  Citation: 1089

  Authors: Folkert O., James H.

• The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

  Citation: 1012

  Authors: Camille N., Deepali, Angela M., Shirish, Sunwen, Lara, Atul

• A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1

  Citation: 931

  Authors: John D., Joshua, Mark H., Flavio, Ronald S.

• Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

  Citation: 912

  Authors: Olle, Mehmet, Ida, Mats, Berit, Helena, Hanns-Ulrich, Aldona, Attila, Zuzana, Brigitta, Johan, Lisbeth, Katarina

• A Comprehensive Risk Quantification Score for Deceased Donor Kidneys: The Kidney Donor Risk Index

  Citation: 907

  Authors: Panduranga S., Douglas E., Mary K., Kenneth A., Robert A., Robert M., Friedrich K., Randall S.

---